Around four in a thousand people worldwide suffer from schizophrenia, according to scientific estimates. The disease affects people from all walks of life. The disease touches men and women equally.
Despite its prevalence, however, schizophrenia has remained a mystery. Diagnosis has relied on patient behavior, such as hallucinations, delusions and disordered thinking, rather than on quantitative biomarkers. As a result, psychiatrists' ability to objectively diagnose and treat people with the illness has been impaired.
New research may change this situation, though. The scientists have recently developed a novel imaging marker that may help in the personalized medicine of psychiatric disorders.
The study, published in Nature Medicine, shows that abnormal striatal function can be a promising biomarker for the diagnosis of schizophrenia and treatment response.
In their search for suitable biomarkers, the scientists collected multimodal neuroimaging data from a total of 1100 individuals with schizophrenia and healthy controls from 2010-15.
Using the large dataset, the researchers first proposed the concept of "functional striatal abnormalities." They then used artificial intelligence technology on resting state fMRI data to map striatal dysfunction at the individual level.
The researchers showed, for the first time, that striatal dysfunction was effective in distinguishing schizophrenia patients and that such dysfunction was also responsible for poorer antipsychotic response.
Based on the newly developed biomarker, the researchers extended their research to other neuropsychiatric disorders. They showed that individuals with bipolar disorder also showed striatal dysfunction that overlapped with the dysfunction associated with schizophrenia.
After combining different levels of data, the researchers suggested that striatal dysfunction is related to the dopaminergic system and polygenic genetic risk for schizophrenia.
The study also evaluated using this biomarker to predict diagnostic labels and treatment responses across several different hospitals.
The scientists hope research on the biological underpinnings of psychiatric disorders will increase understanding of disease mechanisms as well as guide new drug development.
http://english.cas.cn/newsroom/research_news/life/202003/t20200324_231710.shtml
https://www.nature.com/articles/s41591-020-0793-8
A neuroimaging biomarker for striatal dysfunction in schizophrenia
- 1,302 views
- Added
Edited
Latest News
Gut bacteria may eliminate pathogens by competing for energy resources
How deep brain stimulation treats Parkinson's disease symptoms
Plasma membrane phospholipid plays a key role in epithelial cell adhesion
COVID-19, MIS-C and Kawasaki disease share same immune response
Improved cognition and mood by inducing neurogenesis via optogenetic stimulation of the brain
Other Top Stories
Cellular clock regulating human spine development
UV exposure causes estrogen mediated DNA damage and vision loss mostly in females
Reactivating neurogenesis improves learning and memory in old mice
Universal experiences associated with music
New imaging system and artificial intelligence algorithm accurately identify brain tumors
Protocols
Integrating neuroimaging and gene expression data using the imaging transcriptomics toolbox
Antibody structure prediction using interpretable deep learning
A semi-automated workflow for brain Slice Histology Alignment, Registration, and Cell Quantificat…
NanoDam identifies Homeobrain (ARX) and Scarecrow (NKX2.1) as conserved temporal factors in the D…
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays
Publications
FMRP regulates GABAA receptor channel activity to control signal integration in hippocampal granu…
Host cells subdivide nutrient niches into discrete biogeographical microhabitats for gut microbes
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
Maturation of beta cells: lessons from in vivo and in vitro models
Plasma membrane phosphatidylinositol (4,5)-bisphosphate is critical for determination of epitheli…
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER